Uncategorized
NovaBay reports $3.7 million loss in third quarter
NovaBay Pharmaceuticals reported a net loss of $3.7 million, or $0.34 per share, in the third quarter compared with a net loss of $5.2 million, or $1.77 per share, in the third quarter of last year. Net sales increased from $1.2 million a year ago to $3.4 million in the third quarter, according to a company press release.